
GC43108
C8 dihydro Ceramide (d18:0/8:0)
Also known as N-[(2S,3R)-1,3-dihydroxyoctadecan-2-yl]octanamide
C8 dihydro Ceramide (d18:0/8:0) is a negative control of C8 Ceramide· C8-Ceramide (N-Octanoyl-D-erythro-sphingosine) is a cell-permeable analog of naturally occurring ceramides· C8-Ceramide has anti-proliferation properties and acts as a potent chemotherapeutic agent· C8-Ceramide stimulates dendritic cells to promote T cell responses upon virus infections· C8-Ceramide induces slight activation of protein kinase (PKC) in vitro
ChemicalCAS145774-33-0MW427.7FormulaC26H53NO3
- CAS number
- 145774-33-0
- Molecular weight
- 427.7
- Formula
- C26H53NO3
- Solubility
- Chloroform: Soluble,DMSO: Soluble,Ethanol: Soluble
- InChIKey
- LGOFBZUQIUVJFS-LOSJGSFVSA-N
- Catalogue number
- GC43108
- Brand
- GLPBIO
Computed properties PubChem CID 6610274 · XLogP 9 · TPSA 69.6 Ų · H-bond donors 3
- XLogP
- 9
- TPSA
- 69.6 Ų
- H-bond donors
- 3
- H-bond acceptors
- 3
- Rotatable bonds
- 23
- Heavy atoms
- 30
SMILES CCCCCCCCCCCCCCC[C@H]([C@H](CO)NC(=O)CCCCCCC)O
Computed descriptors from PubChem (CID 6610274), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il